AMPICILLIN TRIHYDRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ampicillin Trihydrate, and when can generic versions of Ampicillin Trihydrate launch?
Ampicillin Trihydrate is a drug marketed by Aurobindo Pharma, Belcher Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Strides Pharma, Vitarine, Dava Pharms Inc, and Teva. and is included in sixteen NDAs.
The generic ingredient in AMPICILLIN TRIHYDRATE is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMPICILLIN TRIHYDRATE?
- What are the global sales for AMPICILLIN TRIHYDRATE?
- What is Average Wholesale Price for AMPICILLIN TRIHYDRATE?
Summary for AMPICILLIN TRIHYDRATE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Clinical Trials: | 1 |
Patent Applications: | 243 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMPICILLIN TRIHYDRATE at DailyMed |
![AMPICILLIN TRIHYDRATE drug patent expirations Drug patent expirations by year for AMPICILLIN TRIHYDRATE](/p/graph/s/t/AMPICILLIN_TRIHYDRATE-patent-expirations.png)
Recent Clinical Trials for AMPICILLIN TRIHYDRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for AMPICILLIN TRIHYDRATE
Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for AMPICILLIN TRIHYDRATE
AMPICILLIN TRIHYDRATE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting AMPICILLIN TRIHYDRATE
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purepac Pharm | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061980-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 216554-001 | Oct 31, 2023 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Strides Pharma | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062882-001 | Feb 25, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |